|
SF3B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.830700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.952800E-04 |
| Normal-vs-Stage2 |
6.244500E-04 |
| Normal-vs-Stage3 |
7.084500E-03 |
| Normal-vs-Stage4 |
6.761900E-04 |
| Stage1-vs-Stage2 |
3.446400E-01 |
| Stage1-vs-Stage3 |
7.530800E-01 |
| Stage1-vs-Stage4 |
2.147800E-01 |
| Stage2-vs-Stage3 |
7.072600E-01 |
| Stage2-vs-Stage4 |
3.490400E-01 |
| Stage3-vs-Stage4 |
3.061600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.380300E-03 |
| Normal-vs-AfricanAmerican |
2.898500E-03 |
| Normal-vs-Asian |
2.159400E-03 |
| Caucasian-vs-AfricanAmerican |
5.384400E-01 |
| Caucasian-vs-Asian |
1.763970E-01 |
| AfricanAmerican-vs-Asian |
1.641000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.551800E-04 |
| Normal-vs-Female |
4.849200E-01 |
| Male-vs-Female |
1.555750E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.269990E-02 |
| Normal-vs-Extreme_Weight |
2.562300E-04 |
| Normal-vs-Obese |
3.470100E-02 |
| Normal-vs-Extreme_Obese |
9.586000E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.262600E-01 |
| Normal_Weight-vs-Obese |
4.682600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.980240E-01 |
| Extreme_Weight-vs-Obese |
1.097450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.860800E-01 |
| Obese-vs-Extreme_Obese |
6.033600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.873400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.541900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.537960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.548320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.900800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.122360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.500200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.374200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.700800E-03 |
| Normal-VS-Type2 PRCC |
1.83589999999123E-05 |
| Normal-VS-KIRP CIMP |
2.492800E-01 |
| Normal-VS-Unclassified PRCC |
3.939800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.245960E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.341000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.980610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.276620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.439300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.298600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89870999999231E-05 |
| Normal-vs-N1 |
1.102200E-01 |
| Normal-vs-N2 |
9.861400E-03 |
| N0-vs-N1 |
5.632200E-02 |
| N0-vs-N2 |
6.541400E-01 |
| N1-vs-N2 |
2.494200E-01 |
|
|
